CN Stock MarketDetailed Quotes
002172 Jiangsu Aoyang Health Industry
- 2.35
- +0.02+0.86%
Market Closed Jul 26 15:00 CST
1.80BMarket Cap40.52P/E (TTM)
2.36High2.33Low75.59KlotVolume2.33Open2.33Pre Close17.71MTurnover0.99%Turnover Ratio36.15P/E (Static)765.73MShares4.6452wk High14.42P/B1.80BFloat Cap2.2952wk Low2.56Limit Up765.27MShs Float25.51Historical High2.10Limit Down1.29%Amplitude1.69Historical Low--Dividend TTM2.34Avg Price31.86KlotAsk--Div YieldTTM100Lot Size40.64KlotBid
Jiangsu Aoyang Health Industry Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 2.69%509.72M | -2.68%1.83B | 1.72%1.37B | 45.92%1.03B | -6.93%496.35M | -8.00%1.88B | -7.42%1.35B | -37.43%708.88M | -14.69%533.28M | 3.57%2.04B |
| Refunds of taxes and levies | ---- | -95.56%355.18K | ---- | ---- | ---- | 284.62%8M | 4.09%2.17M | 28.59%2.17M | ---- | -25.41%2.08M |
| Cash received relating to other operating activities | -8.81%167.57M | -47.57%214.78M | -26.34%271.5M | 5.02%289.45M | -15.41%183.77M | -54.46%409.66M | -49.57%368.6M | -52.07%275.62M | 45.78%217.23M | 58.75%899.49M |
| Cash inflows from operating activities | -0.41%677.3M | -11.00%2.05B | -4.42%1.65B | 34.18%1.32B | -9.38%680.11M | -21.98%2.3B | -21.45%1.72B | -42.29%986.67M | -3.12%750.51M | 15.83%2.95B |
| Goods services cash paid | 19.35%657.95M | -11.69%1.45B | -7.53%1.29B | 16.05%856.97M | -34.77%551.3M | -12.29%1.65B | 8.39%1.4B | -28.46%738.46M | 94.76%845.19M | 141.68%1.88B |
| Staff behalf paid | 2.25%94.71M | -5.07%324.94M | -1.99%250.38M | -0.96%173.05M | -10.69%92.63M | -26.14%342.3M | -23.33%255.45M | -17.53%174.74M | -9.57%103.71M | 18.54%463.43M |
| All taxes paid | 9.34%14.91M | 46.44%46.18M | 47.76%39.32M | 36.34%29.05M | 73.14%13.64M | -23.42%31.53M | 27.45%26.61M | 69.28%21.3M | 25.96%7.88M | 0.03%41.18M |
| Cash paid relating to other operating activities | -15.36%121.73M | -46.58%167.43M | -39.56%246.98M | -50.49%125.38M | 23.10%143.83M | -47.69%313.4M | -50.32%408.61M | -37.68%253.22M | 425.21%116.84M | -50.48%599.15M |
| Cash outflows from operating activities | 10.97%889.31M | -14.62%1.99B | -12.41%1.83B | -0.28%1.18B | -25.36%801.39M | -21.72%2.33B | -15.29%2.09B | -28.58%1.19B | 86.02%1.07B | 23.22%2.98B |
| Net cash flows from operating activities | -74.82%-212.02M | 260.65%54.3M | 49.79%-185.03M | 169.35%139.43M | 62.46%-121.28M | -1.01%-33.8M | -33.75%-368.49M | -530.82%-201.05M | -263.58%-323.1M | -126.70%-33.47M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | --6.07M | --2.57M | --2.57M | --34.71M | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -99.91%397.34 | -99.99%105.02K | -99.90%1M | -99.99%63.79K | -99.95%446.88K | 108.05%1.03B | 116.56%1.03B | 116.55%1.03B | 1,148.14%950.8M | 157.36%495.65M |
| Net cash received from disposal of subsidiaries and other business units | ---- | -4.64%24.41M | --6.2M | --6.2M | --3.16M | --25.6M | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | -99.99%397.34 | -97.75%24.52M | -98.71%13.27M | -99.14%8.83M | -99.35%6.18M | 120.22%1.09B | 69.35%1.03B | 70.17%1.03B | 340.07%950.8M | -68.51%495.65M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -37.21%13.18M | -67.08%63.59M | -72.93%46.61M | -73.64%44.19M | -88.28%20.99M | -12.64%193.17M | -46.68%172.18M | -10.73%167.63M | 98.79%179.06M | 24.77%221.12M |
| Cash paid to acquire investments | ---- | 160.75%4.76M | --4.76M | --1M | ---- | --1.82M | ---- | ---- | --10K | ---- |
| Net cash paid to acquire subsidiaries and other business units | --2.61M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | -50.00%5M | ---- | ---- | ---- | -96.91%10M | ---- |
| Cash outflows from investing activities | -39.25%15.79M | -64.95%68.35M | -70.17%51.37M | -73.04%45.19M | -86.26%25.99M | -11.81%194.99M | -61.39%172.18M | -45.53%167.63M | -54.26%189.07M | -86.45%221.12M |
| Net cash flows from investing activities | 20.29%-15.79M | -104.89%-43.84M | -104.43%-38.09M | -104.21%-36.35M | -102.60%-19.81M | 226.56%896.52M | 425.85%859.85M | 189.41%864.39M | 486.04%761.73M | 570.78%274.54M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | --1.5M | --1.5M | --1.5M | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 76.64%576.42M | -3.83%1.57B | -14.53%1.35B | -10.11%878.87M | -56.12%326.33M | -25.41%1.63B | -21.83%1.58B | -2.40%977.76M | 5.09%743.76M | -3.08%2.19B |
| Cash received relating to other financing activities | -57.42%95.42M | -13.09%430.31M | 71.98%382.87M | 141.22%380.09M | -5.93%224.11M | -52.17%495.14M | -58.21%222.63M | -25.20%157.57M | 11,412.50%238.24M | 88.77%1.04B |
| Cash inflows from financing activities | 21.73%671.85M | -5.99%2B | -3.75%1.73B | 11.02%1.26B | -43.79%551.93M | -34.00%2.13B | -29.43%1.8B | -6.36%1.14B | 38.35%981.99M | 14.86%3.23B |
| Borrowing repayment | 4.52%345.84M | -16.68%1.55B | -28.61%1.17B | -26.11%827.23M | -60.12%330.89M | -39.01%1.86B | -17.70%1.63B | -2.66%1.12B | -11.05%829.73M | 18.42%3.06B |
| Dividend interest payment | -12.01%10.55M | -25.76%36.82M | -10.53%32.57M | -8.96%22.02M | 67.88%11.99M | -54.92%49.6M | -60.09%36.4M | -60.90%24.19M | -76.24%7.14M | -7.73%110.03M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | 64.29%2.25M | --2.25M | --2.25M | ---- | --1.37M | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -89.80%22.88M | -50.61%422.16M | -31.02%364.43M | 4.78%518.32M | -51.36%224.22M | 35.67%854.69M | 33.89%528.3M | 71.13%494.68M | 2,731.28%460.94M | 580.28%629.99M |
| Cash outflows from financing activities | -33.12%379.27M | -27.31%2.01B | -28.89%1.56B | -16.53%1.37B | -56.30%567.1M | -27.08%2.77B | -11.02%2.2B | 9.15%1.64B | 32.54%1.3B | 35.93%3.8B |
| Net cash flows from financing activities | 2,028.84%292.58M | 98.22%-11.43M | 142.42%169.15M | 78.71%-107.11M | 95.20%-15.17M | -11.91%-640.33M | -601.53%-398.74M | -74.33%-503.1M | -17.24%-315.82M | -4,083.05%-572.19M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 114.98%1.69K | -75.46%16.22K | -60.87%29.55K | 26.39%35.87K | 28.26%-11.28K | 334.16%66.08K | -98.93%75.53K | -25.15%28.38K | -20.19%-15.72K | -386.80%-28.22K |
| Net increase in cash and cash equivalents | 141.45%64.77M | -100.42%-944.27K | -158.19%-53.94M | -102.49%-4M | -227.27%-156.27M | 167.18%222.46M | 464.24%92.7M | 182.19%160.28M | 145.61%122.79M | -506.87%-331.15M |
| Add:Begin period cash and cash equivalents | -0.27%353.97M | 167.95%354.92M | 167.95%354.92M | 167.95%354.92M | 167.95%354.92M | -71.43%132.46M | -71.43%132.46M | -71.43%132.46M | -71.43%132.46M | 21.29%463.61M |
| End period cash equivalent | 110.79%418.74M | -0.27%353.97M | 33.67%300.97M | 19.88%350.92M | -22.17%198.65M | 167.95%354.92M | -48.61%225.16M | -43.75%292.73M | 31.28%255.24M | -71.43%132.46M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg